Thu, February 22, 2024
Wed, February 21, 2024
Tue, February 20, 2024
Mon, February 19, 2024
Fri, February 16, 2024

Charles Duncan Reiterated (AXSM) at Buy and Held Target at $108 on, Feb 20th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-108-on-feb-20th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $108 on, Feb 20th, 2024.

Charles has made no other calls on AXSM in the last 4 months.



There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Charles


  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $112 on, Friday, February 16th, 2024
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
  • Leonid Timashev of "RBC Capital" Initiated at Buy and Held Target at $126 on, Thursday, January 25th, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 26th, 2023
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023

Publication Contributing Sources